KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Goodwill (2019 - 2025)

Historic Goodwill for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $421.7 million.

  • GoodRx Holdings' Goodwill rose 266.57% to $421.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $421.7 million, marking a year-over-year increase of 266.57%. This contributed to the annual value of $410.8 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that GoodRx Holdings reported Goodwill of $421.7 million as of Q3 2025, which was up 266.57% from $421.7 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Goodwill registered a high of $421.7 million during Q1 2025, and its lowest value of $261.1 million during Q1 2021.
  • Moreover, its 5-year median value for Goodwill was $410.8 million (2023), whereas its average is $388.1 million.
  • In the last 5 years, GoodRx Holdings' Goodwill skyrocketed by 2968.81% in 2022 and then plummeted by 75.59% in 2023.
  • Over the past 5 years, GoodRx Holdings' Goodwill (Quarter) stood at $329.7 million in 2021, then grew by 25.0% to $412.1 million in 2022, then decreased by 0.33% to $410.8 million in 2023, then changed by 0.0% to $410.8 million in 2024, then grew by 2.67% to $421.7 million in 2025.
  • Its Goodwill stands at $421.7 million for Q3 2025, versus $421.7 million for Q2 2025 and $421.7 million for Q1 2025.